JP2023526418A5 - - Google Patents
Info
- Publication number
- JP2023526418A5 JP2023526418A5 JP2022570478A JP2022570478A JP2023526418A5 JP 2023526418 A5 JP2023526418 A5 JP 2023526418A5 JP 2022570478 A JP2022570478 A JP 2022570478A JP 2022570478 A JP2022570478 A JP 2022570478A JP 2023526418 A5 JP2023526418 A5 JP 2023526418A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- composition according
- salt
- 25hc3s
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063029364P | 2020-05-22 | 2020-05-22 | |
| US63/029,364 | 2020-05-22 | ||
| US202063030213P | 2020-05-26 | 2020-05-26 | |
| US63/030,213 | 2020-05-26 | ||
| US202063113119P | 2020-11-12 | 2020-11-12 | |
| US63/113,119 | 2020-11-12 | ||
| US202163146556P | 2021-02-05 | 2021-02-05 | |
| US63/146,556 | 2021-02-05 | ||
| PCT/US2021/033746 WO2021237146A1 (en) | 2020-05-22 | 2021-05-21 | Treatment of non-alcoholic steatohepatitis (nash) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023526418A JP2023526418A (ja) | 2023-06-21 |
| JP2023526418A5 true JP2023526418A5 (enExample) | 2024-05-28 |
Family
ID=78707648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022570478A Pending JP2023526418A (ja) | 2020-05-22 | 2021-05-21 | 非アルコール性脂肪性肝炎（ｎａｓｈ）の処置 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230181602A1 (enExample) |
| EP (1) | EP4153165A4 (enExample) |
| JP (1) | JP2023526418A (enExample) |
| KR (1) | KR20230015940A (enExample) |
| CN (1) | CN115803061A (enExample) |
| AU (1) | AU2021273937A1 (enExample) |
| BR (1) | BR112022023128A2 (enExample) |
| CA (1) | CA3183119A1 (enExample) |
| MX (1) | MX2022014574A (enExample) |
| TW (1) | TW202210082A (enExample) |
| WO (1) | WO2021237146A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3494125T (pt) | 2016-08-02 | 2022-07-07 | Durect Corp | Composições compreendendo 5-colesten-3, 25-diol, 3-sulfato (25hc3s), ou seu sal farmaceuticamente aceitável, e, pelo menos, um oligossacárido cíclico |
| KR20260004765A (ko) * | 2024-07-02 | 2026-01-09 | 건국대학교 글로컬산학협력단 | 스타틴이 결합된 담즙산을 포함하는 대사성 질환의 예방 또는 치료용 약학적 조성물 및 이의 제조방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8399441B2 (en) * | 2004-10-25 | 2013-03-19 | Virginia Commonwealth University | Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis |
| WO2006047022A1 (en) * | 2004-10-25 | 2006-05-04 | Virginia Commonwealth University | Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis |
| US9034859B2 (en) * | 2011-04-06 | 2015-05-19 | Virginia Commonwealth University | Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation |
| CA2904129A1 (en) * | 2013-03-15 | 2014-09-18 | Mochida Pharmaceutical Co., Ltd. | Compositions and methods for treating non-alcoholic steatohepatitis |
| BR112019001225A2 (pt) * | 2016-08-02 | 2019-04-30 | Durect Corporation | composições compreendendo sulfato de colesterol oxigenado e pelo menos um dentre polialquileno glicol, carboximetil celulose e polioxilglicerídeo |
| CN110536683A (zh) * | 2017-04-18 | 2019-12-03 | 基恩菲特公司 | 包含PPAR激动剂如伊拉非诺和乙酰CoA羧化酶ACC抑制剂的组合 |
| TWI814744B (zh) * | 2017-10-06 | 2023-09-11 | 美商基利科學股份有限公司 | 包含acc抑制劑之組合療法 |
-
2021
- 2021-05-21 US US17/924,103 patent/US20230181602A1/en active Pending
- 2021-05-21 CA CA3183119A patent/CA3183119A1/en active Pending
- 2021-05-21 TW TW110118459A patent/TW202210082A/zh unknown
- 2021-05-21 MX MX2022014574A patent/MX2022014574A/es unknown
- 2021-05-21 AU AU2021273937A patent/AU2021273937A1/en active Pending
- 2021-05-21 CN CN202180049250.2A patent/CN115803061A/zh active Pending
- 2021-05-21 EP EP21809835.8A patent/EP4153165A4/en active Pending
- 2021-05-21 BR BR112022023128A patent/BR112022023128A2/pt not_active Application Discontinuation
- 2021-05-21 JP JP2022570478A patent/JP2023526418A/ja active Pending
- 2021-05-21 KR KR1020227043977A patent/KR20230015940A/ko active Pending
- 2021-05-21 WO PCT/US2021/033746 patent/WO2021237146A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101465715B1 (ko) | 심혈관 이벤트 발병 예방용 조성물 | |
| HRP20250797T1 (hr) | Postupci za liječenje pacijenata s obiteljskom hiperkolesterolemijom | |
| JP2019048843A5 (enExample) | ||
| RU2010133489A (ru) | Применение ингибиторов гамма-секретазы для лечения рака | |
| RU2008144136A (ru) | Твердая пероральная лекарственная форма, содержащая усилитель | |
| US6673831B1 (en) | Combination therapy for reducing the risks associated with cardiovascular disease | |
| CA2251972A1 (en) | Combination therapy for reducing the risks associated with cardiovascular disease | |
| JP2018508551A5 (ja) | 心血管疾患を処置するか又は心血管疾患のリスクを低減させるためのｅｔｃ１００２及び１種以上のスタチンを含む固定用量組合せ物 | |
| JP2024507810A5 (enExample) | ||
| CN101939001B (zh) | 用于治疗卵巢癌的含有紫杉醇的组合 | |
| IL274414B1 (en) | Oral rifamycin sv compositions | |
| JP2023538522A5 (enExample) | ||
| IL310115A (en) | Treatment of his hyporesponders | |
| WO2008011178A2 (en) | Compositions comprising omega-3 fatty acids, and their use in treating peripheral artery disease and intermittent claudication | |
| JP2023522415A5 (enExample) | ||
| JP2023527153A5 (enExample) | ||
| US20140314844A1 (en) | Oral complex formulation comprising omega-3 fatty acid and hmg-coa reductase inhibitor with improved stability | |
| JP2022177119A5 (enExample) | ||
| US20060188529A1 (en) | Stable compositions of fenofibrate with fatty acid esters | |
| US6890941B1 (en) | Compositions containing HMG Co-A reductase inhibitors and policosanol | |
| RU2007149337A (ru) | Новый способ лечения гиперлипидемии | |
| CN102416015A (zh) | 一种含他汀类药物的组合物及其用途 | |
| CN101897967A (zh) | 一种治疗血脂异常的沙棘黄酮复方制剂 | |
| Brinton | Newer HMG‐CoA reductase inhibitor (statin) therapies | |
| KR20130003502A (ko) | 오메가-3 지방산 또는 이의 에스테르 및 하이드록시메틸글루타닐 코엔자임에이 환원효소 억제제를 포함하는 경구용 복합 제제 |